Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 175 of 3173 entries
View as:

A Phase I Trial to Investigate the Safety and Tolerability of PF-06412562

Phase: N/A Priority: Normal
NCT ID: NCT01914796 Org: User:
Start: 08/31/13 End: 12/31/13 Due: 12/31/14

Varenicline (Champix®) Special Investigation (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal
NCT ID: NCT01061710 Org: User:
Start: 07/31/10 End: 02/28/14 Due: 02/28/15

A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese Adults

Phase: N/A Priority: Normal
NCT ID: NCT03597217 Org: User:
Start: 08/27/18 End: 11/15/18 Due: 11/15/19

A Study to Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06568731 Org: User:
Start: 08/23/24 End: 12/18/24 Due: 12/18/25

Safety and Efficacy of Lorbrena

Phase: N/A Priority: Normal
NCT ID: NCT03844464 Org: User:
Start: 01/21/19 End: 04/30/26 Due: 04/30/27

A Study to Learn How the Medicine Called [14C] PF-06821497 is Taken up Into and Removed From the Body.

Phase: N/A Priority: Normal
NCT ID: NCT06392230 Org: User:
Start: 08/30/24 End: 11/11/24 Due: 11/11/25

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04557449 Org: User:
Start: 09/23/20 End: 11/23/27 Due: 11/23/28

A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides

Phase: N/A Priority: Normal
NCT ID: NCT00134498 Org: User:
Start: 02/28/05 End: 11/30/06 Due: 11/30/07

Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00147537 Org: User:
Start: 02/28/05 End: 08/31/11 Due: 08/31/12

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT04648241 Org: User:
Start: 01/18/21 End: 02/21/22 Due: 02/21/23

Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept

Phase: N/A Priority: Normal
NCT ID: NCT00992394 Org: User:
Start: 01/31/10 End: 04/30/13 Due: 04/30/14

Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis Media

Phase: N/A Priority: Normal
NCT ID: NCT00360100 Org: User:
Start: 08/31/06 End: 12/31/06 Due: 12/31/07

A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT01092832 Org: User:
Start: 10/31/10 End: 06/30/13 Due: 06/30/14

Actual Use Trial of Ibuprofen 400 mg

Phase: N/A Priority: Normal
NCT ID: NCT02294019 Org: User:
Start: 11/30/14 End: 05/31/15 Due: 05/31/16

Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)

Phase: N/A Priority: Normal
NCT ID: NCT00150202 Org: User:
Start: 07/31/04 End: 10/31/06 Due: 10/31/07

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data

Phase: N/A Priority: Normal
NCT ID: NCT05438888 Org: User:
Start: 07/01/22 End: 10/19/22 Due: 10/19/23

Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04628780 Org: User:
Start: 12/16/20 End: 05/26/23 Due: 05/26/24

Multiple Oral Dose Safety, Tolerability And Pharmacokinetic Study Of PF-04287881 In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01026545 Org: User:
Start: 12/31/09 End: 07/31/10 Due: 07/31/11

Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)

Phase: N/A Priority: Normal
NCT ID: NCT01050634 Org: User:
Start: 11/30/05 End: 04/30/09 Due: 04/30/10

Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00887224 Org: User:
Start: 06/30/09 End: 03/31/11 Due: 03/31/12

Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00831506 Org: User:
Start: 02/28/09 End: 05/31/09 Due: 05/31/10

A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT01634789 Org: User:
Start: 08/31/12 End: 11/30/12 Due: 11/30/13

PH-797804 LPS Study in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02084485 Org: User:
Start: 09/30/06 End: 03/31/08 Due: 03/31/09

Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT04526574 Org: User:
Start: 09/01/20 End: 06/29/21 Due: 06/29/22

Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.

Phase: N/A Priority: Normal
NCT ID: NCT03769194 Org: User:
Start: 12/17/18 End: 10/02/20 Due: 10/02/21